To conclude, our comprehensive analyses identified PTP4A3, NAPRT, and RECQL4 were co-amplified and co-expressed specifically in LEP/MIP adenocarcinoma, and RECQL4 was upregulated in the MIP group. The gene discussed is PTP4A3; the disease is adenocarcinoma.